Fundamental dimension Equity attribute | MNRLeader $10.87▲+2.45% Cap $1.81BP/E 19.1x QuantScore65/100 | CRTPeer $13.86▲+1.91% Cap $83.16MP/E 26.7x QuantScore65/100 | MTRPeer $2.03▼-1.93% Cap $3.78MP/E 10.9x QuantScore52/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical Trend, RSI, MACD & signal consensus | |||
61/100 |
84/100 |
25/100 |
Valuation Multiples, PEG & DCF upside | 96/100 | 72/100 | 100/100 |
Health Piotroski, Altman Z, leverage & liquidity | 35/100 | 79/100 | 50/100 |
Growth Revenue / earnings growth & margins | 70/100 | 25/100 | 33/100 |
Sentiment Analyst ratings, targets & revisions | 63/100 | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 19.1x | 26.7x | 10.9x |
Forward P/E (next FY) | 7.9x | — | — |
EV / EBITDA (TTM) | 6.0x | 24.6x | 4.7x |
Price / Sales | 1.3x | 19.4x | 7.1x |
Price / Free Cash Flow | 11.4x | — | — |
PEG ratio | -0.27 | -0.61 | -1.14 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 3 / 9 | 2 / 9 |
Altman Z-Score | 1.10 (Distress) | 32.11 (Safe) | 20.45 (Safe) |
Total debt / equity | 0.65 | 0.00 | 0.00 |
Quick ratio | 0.8x | 6.7x | — |
Interest coverage | 7.8x | — | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +21.2% | -11.8% | -19.3% |
Net income growth YoY | +54.4% | -20.9% | +10.4% |
Gross margin (TTM) | 53.2% | 96.7% | 85.3% |
Operating margin (FY) | 28.5% | 77.6% | 71.4% |
FCF margin (FY) | 20.1% | 0.0% | 0.0% |
5. Trailing price performancePrice change over period |
1M return | +3.3% | +13.1% | -14.7% |
3M return | -18.8% | +36.6% | -29.8% |
6M return | -16.6% | +30.5% | -56.4% |
Year to date | -1.5% | +74.3% | -53.0% |
1Y return | -10.8% | +76.1% | -58.7% |
3Y return | -40.7% | -24.1% | -84.8% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $202.37 +1761.7% upside | $20.51 +48.0% upside | $4.50 +121.6% upside |
Wall Street consensus target | $17.75 +63.3% · range $16.00–$20.00 | — — | — — |
Consensus stance | 53% Buy40% Hold7% Sell | — | — |